Cyteir Therapeutics CEO Markus Renschler's 2021 pay jumps 376% to $3.5M
Cyteir Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Cyteir Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Cyteir Therapeutics received on average a compensation package of $1.9M, a 195% increase compared to previous year.
Average pay of disclosed executives at Cyteir Therapeutics
Markus Renschler, Chief Executive Officer, received $3.5M in total, which increased by 376% compared to 2020. 79% of Renschler's compensation, or $2.8M, was in option awards. Renschler also received $228K in non-equity incentive plan and $504K in salary.
Andrew Gengos, Chief Business Officer, received a compensation package of $1.1M, which increased by 60% compared to previous year. 51% of the compensation package, or $555K, was in option awards.
Paul Secrist, Chief Scientific Officer, earned $1.1M in 2021, a 113% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2022.